Asthma Pathophysiology, Discharge, and Education Plan
This paper examines the pathophysiology of asthma as a chronic respiratory condition affecting millions of children worldwide and outlines a comprehensive discharge and education plan for a pediatric patient. The plan addresses the correct use of nebulizers and metered dose inhalers, indications for emergency department visits, and the combined use of oral and inhaled corticosteroids alongside beta2 agonists. The paper also emphasizes the importance of follow-up care, inhaled steroid adherence between exacerbations, and the role of patient and family education in achieving long-term symptom control.
- Asthma Pathophysiology Overview: Epidemiology and chronic airway inflammation in children
- Discharge and Education Plan: Inhaler use, emergency criteria, and follow-up guidance
- Corticosteroid Therapy and Exacerbation Management: Oral and inhaled corticosteroid dosing for exacerbations
- Inhaler Technique and Spacer Devices: Beta2 agonist delivery and homemade spacer effectiveness
- Post-Discharge Follow-Up and Ongoing Management: Sustained inhaled steroid adherence after discharge
- References: Cited clinical guidelines and journal sources
✍️ How to write this paper — guide, tools & examples ▾
What makes this paper effective
- Integrates clinical guidelines from multiple sources (CCHMC, Kovesi, Pollart) to support each recommendation, lending evidence-based credibility to the discharge plan.
- Applies general pathophysiology directly to a specific pediatric case (a six-year-old patient), grounding abstract concepts in practical clinical decision-making.
- Covers the full care continuum from acute emergency management through home maintenance therapy, demonstrating a systems-level approach to asthma care.
Key academic technique demonstrated
The paper demonstrates synthesis of clinical guidelines into a patient-specific care plan. Rather than simply reporting what guidelines say, it links dosing regimens, device selection, and follow-up timelines to the individual patient's age and presentation, showing how evidence-based practice is applied at the bedside.
Structure breakdown
The paper opens with a brief overview of asthma epidemiology and pathophysiology, establishing the clinical context. It then transitions into a detailed discharge and education plan covering pharmacological therapy (oral and inhaled corticosteroids, beta2 agonists), inhaler and spacer device guidance, and post-discharge follow-up care. The argument builds logically from disease understanding to practical management, concluding with the importance of ongoing inhaled steroid adherence. A reference list in APA format closes the paper.
Asthma Pathophysiology Overview
Asthma is a respiratory tract disease reported to afflict approximately 300 million persons worldwide, with prevalence projected to increase (CCHMC, 2010). It is characterized by chronic and recurring inflammation and obstruction of the airways, expressed through wheezing or coughing. Asthma has been identified as the leading chronic ailment among children (AsthmaCure, 2010). About 50% of cases subside when affected children reach age 13 or 14. In the meantime, those who are stricken must contend with the current understanding that symptoms remain entirely incurable. Nonetheless, they can be substantially controlled with adequate education, appropriate treatment, and a management plan established by a supervising physician. An important part of that success is sufficient knowledge about the disease and faithful adherence to the prescribed treatment and management plan (AsthmaCure, 2010).
Discharge and Education Plan
The discharge and education plan includes the treatment plan itself and instruction on the correct use of the nebulizer and metered dose inhaler for home use by the child (Kovesi et al., 2010). It contains all necessary information on when the child must be taken to the emergency department. A recent study found that a single visit to the emergency department may make future unscheduled visits unnecessary. The study also recommended a follow-up appointment with a primary care physician or asthma specialist within 4–8 weeks to evaluate the entire therapy management and maintenance dose, especially when the regimen includes regular use of inhaled corticosteroids (Kovesi et al., 2010).
Corticosteroid Therapy and Exacerbation Management
A major component of the plan is the administration of prescribed oral corticosteroids in combination with the inhaled mode to prevent further exacerbations (Pollart et al., 2011). These exacerbations may be mild, moderate, severe, or fatal, as determined by symptoms, physical findings, and other clinical criteria (CCHMC, 2010). These criteria include lung function and oxygen saturation. Oral corticosteroids are typically administered for one to ten days; however, a regimen of 1 mg per kg of prednisone for three days has been shown to be as effective as a five-day course in fully resolving symptoms within one week for children aged 2–15, which includes the six-year-old in this case (Pollart et al., 2011; CCHMC, 2010).
Create your account
Always verify citation format against your institution’s current style guide requirements.